—
C+
C+ The full Closelooknet — membership. Open the C+ overview

CellaVision AB (CEVI.ST) — chart, structure and Closelooknet read

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for CEVI.ST, from the same nightly bakes the boards use. Research diary readings, not advice.

Versus its index Euro-AI 50 — the name, its sleeve and the index over day, week and month

Versus its index

The name against its Closelooknet index and its own sleeve — equal-weight, nightly closes.

Euro-AI 50 · as of 2026-09-25

DayWeekMonth3 months
CEVI.ST+5.0%+7.1%+6.1%+28.3%
Euro-AI 50+0.4%+1.8%−3.7%—

Against the index: 5.3 pts ahead on the week, 9.8 pts ahead on the month.

Returns from the index workers’ nightly closes; equal-weight sleeves. A relative reading from the research diary, not advice.

Weather around the name 4 macro readings: Money Temperature, Factor regime, Sector × region …

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 62/100 · S&P 500 fund at 67, bullish alignedEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-09-25
  • Factor regime Momentum leading — risk appetite buildingMomentum against low volatility (SPMO / SPLV): above its 50-day trend, 99th percentile of the window, +8.4% over 20 sessions. Factor regime → 2026-09-25
  • Sector × region Health care in Europe: +0.1% week · −3.6% month · −4.6% quarter · −1.5% yearThe Sector Engine cell this name lives in, from EXV4.XETRA; the 11 × 4 matrix shows where its sector is being bought and where it is being sold. Sector Engine → 2026-09-27
  • Sovereign pressure Index 0.61 · up 0.29 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-09-25
Who it is priced against Medical Devices · 8 names with week and year-to-date

Peer group

Medical Devices

Names in the same industry from the Closelooknet universe; scored names rank on their Closelooknet score, the rest on trend state.

Compared against CEVI.ST on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — CellaVision AB

CEVI.ST in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
CellaVision designs microscopy instruments, software and reagents that automate the reading of blood and body-fluid samples in laboratories. Its systems analyse blood cell differentials, bone marrow aspirates and body fluid preparations, replacing manual microscope review with digital image capture and software classification. It sells to hospitals and commercial laboratories worldwide and is based in Lund, Sweden.
Where it sits in the stack
CellaVision carries no seat in Rubin, our AI build-out index, so it sits outside that stack. It belongs to the Healthcare sector of our universe, within medical devices, where its instruments automate a diagnostic task rather than build compute infrastructure.
Who it is priced against
The diary groups it with other scored healthcare names, a peer set built from names across the sector rather than a narrow niche, including argenx, Eli Lilly, Medpace, BeiGene, UCB, Fisher & Paykel Healthcare and Globus Medical. The market also compares it with Sysmex, which competes in blood analysis instruments.
Why Closelooknet tracks it
CellaVision holds a seat in our Euro-AI 50 index and carries a Closelooknet score, with quality the strongest module and valuation the weakest. The diary has not yet logged a quote on the name.
What the diary watches
Whether the valuation module improves or stays the weak point as the quality module continues to lead the score.

CellaVision AB (CEVI.ST) trades on the ST exchange in Sweden, classified under Healthcare. Constituent of Euro-AI 50.

The Closelooknet company score reads 55/100 composite (momentum 74, quality 69, valuation 32) across 7 modules — the full breakdown, chart structure and analog history load live above.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

Dividends and capital return trailing yield 1.57%, annual · last 2.75 SEK on 2026-04-29

Dividends and capital return

What CEVI.ST pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 2.75 SEK per share · a 1.57% yield on the 2026-09-25 close 1 distribution, paid once a year 2026-09-25
  • Change on the year +10.0% against the prior twelve months prior twelve months 2.50 SEK per share
  • Last distribution 2.75 SEK per share as the price series records it, within days of the ex-date 2026-04-29
  • By calendar year 2024: 2.25 SEK (partial) · 2025: 2.50 SEK · 2026: 2.75 SEK to date first distribution recorded in the three-year window: 2024-05-06
  • Dividends paid, FY2025 60 m SEK 51% of earnings
  • Share count 0.0% in FY2025
  • Capital returned 60 m SEK · 33% of free cash flow dividends and buybacks together, against the year’s free cash flow

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-09-26

Quick answers

What is CellaVision AB (CEVI.ST)?

CellaVision AB trades as CEVI.ST on the ST exchange (Sweden) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-09-26.

Is CEVI.ST in a Closelooknet index?

Yes — CellaVision AB is a constituent of Euro-AI 50, as of 2026-09-26.

What is CellaVision AB's Closelooknet composite score?

55 out of 100, with momentum 74, quality 69 and valuation 32 sub-scores, as of 2026-09-26. Scores are Closelooknet's own research readings, not ratings or investment advice.

Where does CEVI.ST trade against its moving averages?

Stochastic turned down: Its stochastic crossed down from overbought (%K 87.1 under %D 87.8) today — momentum is cooling. As of 2026-09-24 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How is CEVI.ST doing against its Closelooknet index?

Over the past month CellaVision AB is +6.1% against −3.7% for the Euro-AI 50 — 9.8 points ahead of its index, as of 2026-09-25. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.

What does CellaVision AB do?

CellaVision designs microscopy instruments, software and reagents that automate the reading of blood and body-fluid samples in laboratories. Its systems analyse blood cell differentials, bone marrow aspirates and body fluid preparations, replacing manual microscope review with digital image capture and software classification. It sells to hospitals and commercial laboratories worldwide and is based in Lund, Sweden. The diary groups it with other scored healthcare names, a peer set built from names across the sector rather than a narrow niche, including argenx, Eli Lilly, Medpace, BeiGene, UCB, Fisher & Paykel Healthcare and Globus Medical. The market also compares it with Sysmex, which competes in blood analysis instruments.

Where does CellaVision AB sit in the AI build-out?

CellaVision carries no seat in Rubin, our AI build-out index, so it sits outside that stack. It belongs to the Healthcare sector of our universe, within medical devices, where its instruments automate a diagnostic task rather than build compute infrastructure. CellaVision holds a seat in our Euro-AI 50 index and carries a Closelooknet score, with quality the strongest module and valuation the weakest. The diary has not yet logged a quote on the name.

Does CellaVision AB pay a dividend?

CellaVision AB has paid 2.75 SEK per share over the last twelve months, paid once a year, a trailing yield of 1.57% on the 2026-09-25 close; the last distribution recorded in the price series was 2.75 SEK on 2026-04-29. In fiscal 2025 the company paid 60 m SEK in dividends, 33% of that year’s free cash flow. The share count was unchanged over the fiscal year. The "Dividends and capital return" block on this page carries the lines.

What does this page show?

A live price chart with SMA overlays and drawing tools for CEVI.ST, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

Related in the Closelooknet universe

same Closelooknet index seat first, then Medical Devices. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.